NIH Working Group Proposes Major Reforms for Postdoctoral Researchers Amid Rising Industry Losses
A National Institutes of Health (NIH) working group proposed significant changes to improve the conditions for [...]
FDA Approves Merck’s Welireg for Expanded Use in Kidney Cancer, Boosting Sales Prospects
Merck’s cancer drug Welireg (belzutifan), approved in August 2021, has been making steady sales progress. Recently, [...]
U.S. Health Spending Normalizes Post-Pandemic with a Decrease in GDP Share
The summary of the recent report on U.S. health spending is as follows: Annual Health Spending [...]
Challenges and Advancements in Rare Disease Research and Patient Care
The definition of a rare disease varies internationally. In the U.S., it's a condition affecting fewer [...]
Montana’s Slow Utilization of Opioid Settlement Funds Amid Rising Crisis
Nearly a year after Montana received millions of dollars from opioid settlement funds, a significant portion [...]
Supreme Court Revisits Abortion Pill Access and FDA’s Authority in Landmark Case
The Supreme Court has agreed to review the accessibility of mifepristone, a commonly used abortion pill, [...]
AstraZeneca Buys Icosavax for $838 Million to Boost Vaccine R&D and Compete in RSV Market
AstraZeneca is acquiring Icosavax for $838 million upfront, aiming to strengthen its vaccine research and development. [...]
ICER Report: Price Hikes for Eight Drugs Lead to $1.3 Billion Increase in U.S. Healthcare Costs
The Institute for Clinical and Economic Review (ICER) reported that price increases for eight drugs led [...]
Revolutionizing Healthcare: Epic and Elevance Health’s Data-Driven, AI-Enhanced Collaboration
The healthcare technology sector is experiencing significant advancements due to the efforts of two major players: [...]
FTC Challenges Sanofi’s Deal for Pompe Disease Treatment, Citing Monopoly Concerns
The Federal Trade Commission (FTC) is challenging Sanofi’s proposed $755 million deal to license Maze Therapeutics’ [...]
FDA Approves Groundbreaking CRISPR Gene-Editing Medicine for Sickle Cell Disease
The FDA has approved the world's first CRISPR gene-editing medicine, Casgevy, for sickle cell disease, marking [...]
Advancements and Challenges in GLP-1 Based Therapies for Diabetes and Obesity
In January 2010, the FDA approved Novo Nordisk's Victoza (liraglutide), a GLP-1 receptor agonist for Type [...]
Implementing Diversity Action Plans in Clinical Trials: Navigating FDA Requirements and Enhancing Inclusivity
In April 2022, the FDA mandated that all Phase 3 and pivotal studies include a Diversity [...]
Global Angiography Catheter Market: Surge in Demand Driven by Minimally Invasive Procedures and Cardiovascular Disease Prevalence
The global angiography catheter market, valued at $1.57 billion in 2024, is expected to grow at [...]
AbbVie Expands Neuroscience Portfolio with $8.7 Billion Acquisition of Cerevel Therapeutics
AbbVie has announced plans to acquire Cerevel Therapeutics, a neuroscience drugmaker, for $8.7 billion, marking its [...]
FDA Gives First Approval for Novartis’ Iptacopan, a Revolutionary Oral Treatment for Rare Blood Disorder PNH
Novartis has received FDA approval for iptacopan, an innovative oral treatment for paroxysmal nocturnal hemoglobinuria (PNH), [...]
Exploring the Potential and Challenges of mRNA Technology in Revolutionizing Flu Vaccines
The article discusses the potential of mRNA technology, popularized during the COVID-19 pandemic, in revolutionizing flu [...]
Navigating Pharmaceutical Sales with Next Best Action 2.0: A Data-Driven Approach
In the ever-evolving pharmaceutical business, the Next Best Action (NBA) approach has emerged as a crucial [...]
Consolidation of US Hospitals Leads to Increased Profits but Not Improved Care Quality, Study Finds
The consolidation of US hospitals increased between 2000 and 2020, with multi-unit hospital systems now owning [...]
UK Biobank Releases Groundbreaking Dataset from Whole Genome Sequencing of 500,000 Participants, Poised to Transform Medical Research
UK Biobank has unveiled a comprehensive dataset from genome sequencing of 500,000 participants, marking a milestone [...]
Samsung Bioepis Set to Launch Stelara Biosimilar in 2025 Amid Challenges for Medicare Price Negotiation Exemption
Samsung Bioepis recently finalized an agreement allowing its Stelara biosimilar, SB17, to launch in February 2025. [...]
Trump Revives ACA Debate, Faces Pushback Amid Biden’s Healthcare Emphasis
Donald Trump has recently reignited the debate over the Affordable Care Act (ACA), also known as [...]
AbbVie Expands Oncology Footprint with $10.1 Billion Acquisition of ImmunoGen
AbbVie, a pharmaceutical giant, announced its plan to acquire ImmunoGen, a clinical-stage biotech company specializing in [...]
Balancing Public Health and Environmental Sustainability: Insights from the Unitaid Report
The recent Unitaid report highlights a complex issue in climate change: the significant environmental impact of [...]
Harvard Researchers Urge Removal of Single Orphan Drug Exemption in Inflation Reduction Act
Biopharma companies are protesting the Inflation Reduction Act's (IRA) pricing negotiations for drugs with multiple orphan [...]